R
Roquefort Therapeutics PLC
LSE:ROQ
Roquefort Therapeutics PLC
LSE:ROQ
Price:
1.1
GBX
Market Closed
Market Cap:
£1.8m
Cash Flow Statement
Cash Flow Statement
Roquefort Therapeutics PLC
Roquefort Therapeutics PLC
Currency: GBP
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|
| Operating Cash Flow | |||||
| Net Income |
(1)
|
(2)
|
(2)
|
(1)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(2)
|
0
|
(0)
|
0
|
|
| Cash from Operating Activities |
(3)
N/A
|
(2)
+40%
|
(2)
-10%
|
(1)
+55%
|
|
| Investing Cash Flow | |||||
| Capital Expenditures |
0
|
0
|
(0)
|
0
|
|
| Other Items |
(1)
|
(0)
|
0
|
0
|
|
| Cash from Investing Activities |
(1)
N/A
|
(0)
+91%
|
(0)
+49%
|
0
N/A
|
|
| Financing Cash Flow | |||||
| Net Issuance of Common Stock |
5
|
3
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
1
|
|
| Other |
(0)
|
(0)
|
(0)
|
0
|
|
| Cash from Financing Activities |
5
N/A
|
3
-33%
|
(0)
N/A
|
1
N/A
|
|
| Change in Cash | |||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
(0)
|
|
| Net Change in Cash |
1
N/A
|
1
+58%
|
(2)
N/A
|
(0)
+89%
|
|
| Free Cash Flow | |||||
| Free Cash Flow |
(3)
N/A
|
(2)
+40%
|
(2)
-13%
|
(1)
+56%
|
|
Switch to:
Switch to:
See Also
Discover More
